about
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX...
Read More
4.62
-0.13
(-2.74%)
24,873
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
enGene Holdings Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..